SUPERSTRING CAPITAL MANAGEMENT LP 13F Portfolio
SUPERSTRING CAPITAL MANAGEMENT LP runs SUPERSTRING CAPITAL MANAGEMENT LP and currently holds 32 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $158.38M. Their top holdings are COGT, AXSM, GMAB, CLDX, TRVI. The top five represent 37.1% of reported portfolio weight. SUPERSTRING CAPITAL MANAGEMENT LP ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, SUPERSTRING CAPITAL MANAGEMENT LP initiated 3 new positions. They added to 10 existing positions. They trimmed 5 positions. Their current best-performing preview position is DFTX with returns of +148.89%.
Portfolio Value
$158.38M
Alpha Score
84.4
#0 of 1000
Holdings
32
SUPERSTRING CAPITAL MANAGEMENT LP Current 13F Holdings
Reported holdings from SUPERSTRING CAPITAL MANAGEMENT LP's latest SEC 13F filing, ranked by portfolio weight.
32 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 COGT COGENT BIOSCIENCES INC | 8.39% | $18.59 | $31.00 | +66.76% | Added +52.46% |
 AXSM AXSOME THERAPEUTICS INC. | 8.33% | $231.84 | $168.35 | -27.39% | Added +380.66% |
 GMAB GENMAB A/S | 7.47% | $27.45 | $37.07 | +35.05% | Added +118.90% |
 CLDX CELLDEX THERAPEUTICS INC NEW | 6.76% | $32.37 | $29.89 | -7.66% | Added +59.73% |
 TRVI TREVI THERAPEUTICS INC | 6.17% | $15.59 | $13.19 | -15.39% | Added +108.38% |
 RVMD REVOLUTION MEDICINES INC | 6.04% | $187.28 | $189.76 | +1.32% | Added +100.00% |
 DFTX DEFINIUM THERAPEUTICS INC | 5.59% | $18.90 | $36.90 | +95.24% | Trimmed -46.43% |
 VIR VIR BIOTECHNOLOGY INC | 5.49% | $9.14 | $11.70 | +28.01% | Added +16.86% |
 IMVT IMMUNOVANT INC | 5.07% | $17.80 | $30.47 | +71.18% | Trimmed -41.73% |
 MPLT MAPLIGHT THERAPEUTICS INC | 2.84% | $20.33 | $8.83 | -56.57% | Trimmed -34.72% |
Showing 1-10 of 32